Cheapest Wegovy Doses In Stock - UK Price £69.00

Our Pricing

Wegovy Doses in Stock UK: Complete Availability Guide

Published on: June 03, 2026

Finding wegovy doses in stock uk has been challenging during recent supply constraints, but Cured Pharmacy now has all dose strengths available with same-day dispatch. Our UK-registered clinical team provides free online consultations in under 3 minutes, with transparent pricing from £79.00 before you start your assessment.

Why Wegovy Doses in Stock UK Matters for Your Weight Loss Journey

Wegovy (semaglutide 2.4mg) requires a structured dose escalation schedule over 16-20 weeks to reach the therapeutic maintenance dose [1]. Missing even one weekly injection can disrupt this titration, potentially causing increased side effects when restarting or delaying your weight loss results.

The STEP 1 clinical trial demonstrated that patients following the complete dose escalation achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. Consistent supply across all dose strengths—0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg—is essential for maintaining this clinically proven schedule.

At Cured Pharmacy, we maintain stock of every Wegovy dose strength to ensure uninterrupted treatment. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees procurement directly with UK-licensed wholesalers, prioritising patients mid-treatment who cannot afford supply gaps.

How Wegovy Semaglutide Works for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural gut hormone involved in appetite regulation and glucose metabolism [2]. When administered weekly via subcutaneous injection, Wegovy acts on specific brain regions that control hunger and food intake, helping patients feel satisfied with smaller portions.

The medication also slows gastric emptying, meaning food stays in your stomach longer, which contributes to prolonged satiety between meals [2]. This dual mechanism—central appetite suppression and peripheral gastric effects—explains why clinical trial participants reported significantly reduced cravings and easier adherence to calorie-controlled diets.

MHRA approval for Wegovy in the UK was granted following extensive Phase 3 trials involving over 4,500 adults with obesity or overweight with weight-related comorbidities [1]. The treatment is licensed specifically for chronic weight management alongside reduced-calorie diet and increased physical activity, not as a standalone solution.

Expected Weight Loss Timeline with Wegovy

Most patients begin noticing appetite changes within the first 2-4 weeks on the initial 0.25mg dose, though significant weight loss typically becomes apparent after reaching the 1mg or 1.7mg doses around weeks 8-12 [1]. The maintenance dose of 2.4mg, reached at week 17, is where maximum therapeutic effect occurs.

In STEP 1, participants lost an average of 6% body weight by week 20, increasing to 10.6% by week 40, and reaching 14.9% by week 68 on the full maintenance dose [1]. Individual results vary based on baseline BMI, dietary adherence, activity levels, and metabolic factors assessed during your clinical consultation.

Wegovy Dose Escalation Schedule Explained

The standard Wegovy titration follows a specific monthly progression: 0.25mg weekly for 4 weeks, then 0.5mg for 4 weeks, 1mg for 4 weeks, 1.7mg for 4 weeks, and finally 2.4mg as the ongoing maintenance dose [3]. This gradual increase allows your digestive system to adapt, significantly reducing the risk of gastrointestinal side effects like nausea and vomiting.

Your UK prescriber may adjust this schedule based on your individual tolerance. If you experience persistent nausea or vomiting at any dose, staying at your current strength for an additional 4 weeks before escalating is a common clinical approach [3]. Never skip doses or attempt to accelerate the schedule without prescriber guidance, as this increases adverse event risk.

Patients who interrupt treatment for more than 2 weeks should contact their prescriber before resuming, as restarting at the previous dose may not be appropriate [3]. Having reliable access to wegovy doses in stock uk through Cured Pharmacy eliminates this concern, ensuring your treatment progresses without forced interruptions.

What Happens If You Miss a Dose

If fewer than 5 days have passed since your missed dose, take it as soon as you remember, then resume your regular weekly schedule [3]. If more than 5 days have elapsed, skip the missed dose entirely and take your next injection on the regularly scheduled day—do not double dose to compensate.

Missing multiple consecutive doses may require restarting at a lower strength to re-establish tolerance, which your prescriber will determine based on how long treatment was interrupted [3]. This is why maintaining continuous supply is clinically important for optimal outcomes.

Wegovy vs Other Weight Loss Injections Available in the UK

Wegovy contains semaglutide, a GLP-1 receptor agonist, while other UK-licensed injectable options include Saxenda (liraglutide, daily injection) and newer dual-agonist treatments. Each has distinct dosing schedules, mechanisms, and clinical efficacy profiles that your prescriber will evaluate based on your medical history and weight loss goals.

Liraglutide requires daily injections at a maximum dose of 3mg, compared to Wegovy's once-weekly 2.4mg administration [2]. Clinical head-to-head data suggests semaglutide produces greater average weight loss—14.9% vs approximately 8% with liraglutide over similar timeframes [1][2]. However, some patients prefer daily dosing for more consistent appetite control throughout the week.

Dual-agonist medications that target both GLP-1 and GIP receptors have shown even higher weight loss in trials, with some participants achieving over 20% body weight reduction [4]. These treatments are now available through UK pharmacies for eligible patients, though they typically carry higher costs than semaglutide-based options.

Who Can Use Wegovy: UK Prescribing Criteria

NICE guidelines recommend GLP-1 receptor agonists like Wegovy for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [5]. Your online assessment with Cured Pharmacy's UK prescribers follows these evidence-based criteria exactly.

Wegovy is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease [3]. Pregnant or breastfeeding women should not use semaglutide, and treatment should be discontinued at least 2 months before planned conception due to the medication's long half-life.

During your free consultation, our clinical team reviews your full medical history, current medications, and previous weight loss attempts to determine suitability. Approximately 15-20% of patients experience side effects significant enough to discontinue treatment [1], which is why proper screening and ongoing monitoring through your patient account is essential.

Common Side Effects and Management

Gastrointestinal side effects—nausea, diarrhoea, vomiting, constipation, and abdominal pain—are the most frequently reported, particularly during dose escalation [1][3]. These typically diminish within 4-8 weeks as your body adapts. Eating smaller, more frequent meals and avoiding high-fat foods can help manage these symptoms.

Rare but serious adverse events include pancreatitis, gallbladder disease, and hypoglycaemia in patients taking concurrent diabetes medications [3]. Contact your prescriber immediately if you experience severe persistent abdominal pain, especially if radiating to your back, as this may indicate pancreatitis requiring urgent assessment.

How to Order Wegovy Doses in Stock UK from Cured Pharmacy

Start by completing our free online clinical assessment, which takes under 3 minutes and covers your medical history, current health conditions, and weight loss goals. Our UK-registered prescribers review every submission individually—this is not an automated process—and typically respond within 2-4 hours during business days.

If approved, your prescription is sent directly to our dispensing team. We stock all Wegovy dose strengths on-site at our GPhC-registered pharmacy (9012511), enabling same-day dispatch for orders placed before 3pm Monday-Friday. All medications are sourced exclusively from UK-licensed wholesalers and arrive in manufacturer-sealed packaging.

Your Wegovy pens ship in discreet, unmarked packaging with no external indication of contents. We include full patient information leaflets, injection technique guides, and sharps disposal information with every order. Track your delivery through your Cured Pharmacy account, and contact our pharmacist team on (+44) 116 4646009 with any questions about storage, administration, or side effects.

Transparent Pricing and Ongoing Prescriptions

Wegovy pricing at Cured Pharmacy starts from £79.00, with the exact cost depending on your prescribed dose strength. Unlike some online services, we display pricing upfront before you begin your consultation—no hidden fees or surprise charges at checkout.

Once established on treatment, you can request repeat prescriptions through your patient account. Our clinical team reviews each repeat request to monitor progress and assess ongoing suitability, in line with MHRA and GPhC guidelines for remote prescribing of prescription-only medicines. We guarantee stock availability for existing patients to prevent treatment interruptions.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to a reduced-calorie diet and increased physical activity alongside medication.